review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Paul Angulo | |
P433 | issue | 6 Pt 2 | |
P921 | main subject | obesity | Q12174 |
metabolic dysfunction–associated steatotic liver disease | Q1546498 | ||
fatty liver disease | Q6058862 | ||
P304 | page(s) | S57-63 | |
P577 | publication date | 2007-06-01 | |
P1433 | published in | Nutrition Reviews | Q15765213 |
P1476 | title | Obesity and nonalcoholic fatty liver disease | |
P478 | volume | 65 |
Q37789176 | Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS. |
Q30403032 | Accuracy of computer-aided ultrasound as compared with magnetic resonance imaging in the evaluation of nonalcoholic fatty liver disease in obese and eutrophic adolescents |
Q33661588 | Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis |
Q36309443 | Adipocyte hypertrophy is associated with lysosomal permeability both in vivo and in vitro: role in adipose tissue inflammation |
Q43289285 | Adipokine serum levels are related to liver histology in severely obese patients undergoing bariatric surgery |
Q34834198 | Altered fatty acid metabolism-related gene expression in liver from morbidly obese women with non-alcoholic fatty liver disease |
Q39596890 | Anti-inflammatory effect of insulin in the human hepatoma cell line HepG2 involves decreased transcription of IL-6 target genes and nuclear exclusion of FOXO1. |
Q38481462 | Are microRNAs the Molecular Link Between Metabolic Syndrome and Alzheimer's Disease? |
Q34864638 | Are women with polycystic ovarian syndrome at a high risk of non-alcoholic Fatty liver disease; a meta-analysis |
Q37550329 | Bitter melon extract attenuating hepatic steatosis may be mediated by FGF21 and AMPK/Sirt1 signaling in mice |
Q36707649 | Cardiorespiratory fitness, waist circumference, and alanine aminotransferase in youth |
Q37196525 | Changes of liver fat content and transaminases in obese children after 12-mo nutritional intervention |
Q38868400 | Childhood Adiposity and Nonalcoholic Fatty Liver Disease in Adulthood |
Q28478084 | Coordinated defects in hepatic long chain fatty acid metabolism and triglyceride accumulation contribute to insulin resistance in non-human primates |
Q38781112 | Cordyceps militaris alleviates non-alcoholic fatty liver disease in ob/ob mice |
Q92502893 | Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) |
Q41580240 | Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMS |
Q40818105 | Ethanol extract of Cirsium japonicum attenuates hepatic lipid accumulation via AMPK activation in human HepG2 cells |
Q37237978 | Exploration of a symptoms experience in people with obesity-related nonalcoholic fatty liver disease. |
Q35550630 | Ezetimibe: its novel effects on the prevention and the treatment of cholesterol gallstones and nonalcoholic Fatty liver disease |
Q36339285 | Folic acid supplementation during high-fat diet feeding restores AMPK activation via an AMP-LKB1-dependent mechanism |
Q35040090 | Glycemic variability is an independent predictive factor for development of hepatic fibrosis in nonalcoholic fatty liver disease |
Q36788693 | Green tea extract provides extensive Nrf2-independent protection against lipid accumulation and NFκB pro- inflammatory responses during nonalcoholic steatohepatitis in mice fed a high-fat diet. |
Q41872219 | Hepatic angiogenesis and fibrosis are common features in morbidly obese patients. |
Q34614334 | Hepatic methionine homeostasis is conserved in C57BL/6N mice on high-fat diet despite major changes in hepatic one-carbon metabolism |
Q42330055 | Hepatic structural enhancement and insulin resistance amelioration due to AT1 receptor blockade |
Q59131888 | High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer Phenotype |
Q37257204 | High fat diet induced hepatic steatosis establishes a permissive microenvironment for colorectal metastases and promotes primary dysplasia in a murine model |
Q50434312 | Improvements of Glucose and Lipid Metabolism After Jejuno-ileal Circuit Procedure in a Non-obese Diabetic Rat Model. |
Q36001686 | Increased Circulating Levels of Alpha-Ketoglutarate in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease |
Q36151646 | Increased levels of systolic blood pressure within the normal range are associated with significantly elevated risks of nonalcoholic fatty liver disease |
Q47744258 | Influence of dietary macronutrients on liver fat accumulation and metabolism. |
Q64355676 | Insights into the Role of PPARβ/δ in NAFLD |
Q37655272 | Lipid overload during gestation and lactation can independently alter lipid homeostasis in offspring and promote metabolic impairment after new challenge to high-fat diet |
Q34103693 | Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease |
Q59353752 | Liver Attenuation, Pericardial Adipose Tissue, Obesity, and Insulin Resistance: The Multi-Ethnic Study of Atherosclerosis (MESA) |
Q37721939 | Liver fat content determined by magnetic resonance imaging and spectroscopy |
Q49376054 | MicroRNA-125a-5p Mediates 3T3-L1 Preadipocyte Proliferation and Differentiation. |
Q33612997 | MicroRNAs in metabolism and metabolic disorders |
Q33890230 | Molecular pathways in non-alcoholic fatty liver disease. |
Q53695403 | Non-Alcoholic Fatty Liver Disease and Associated Factors among Type 2 Diabetic Patients in Southwest Ethiopia. |
Q34578790 | Non-alcoholic fatty liver disease proteomics |
Q33855157 | Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options. |
Q46054372 | Noninvasive laboratory tests proposed for predicting cirrhosis in patients with chronic hepatitis C are also useful in patients with non-alcoholic steatohepatitis |
Q35874842 | Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression |
Q33578954 | Obesity-induced hepatic steatosis is mediated by endoplasmic reticulum stress in the subfornical organ of the brain |
Q41457655 | Peroxisome proliferator-activated receptors as targets to treat non-alcoholic fatty liver disease. |
Q48955354 | Preoperative 4-week supplementation with omega-3 polyunsaturated fatty acids reduces liver volume and facilitates bariatric surgery in morbidly obese patients. |
Q33748493 | Prevalence and Correlates of Suspected Nonalcoholic Fatty Liver Disease in Chinese Children |
Q34415002 | Prevalence and factors associated with nonalcoholic fatty liver disease in Shanghai work-units |
Q41274133 | Prevalence of extreme obesity in a multiethnic cohort of children and adolescents |
Q92974229 | Quantitative Evaluation of Hepatic Steatosis Using Normalized Local Variance in a Rat Model: Comparison with Histopathology as the Reference Standard |
Q34243636 | Reduced dietary omega-6 to omega-3 fatty acid ratio and 12/15-lipoxygenase deficiency are protective against chronic high fat diet-induced steatohepatitis |
Q35900825 | Reduction of TIP47 improves hepatic steatosis and glucose homeostasis in mice |
Q26775340 | Research advances in the relationship between nonalcoholic fatty liver disease and atherosclerosis |
Q46335395 | Retinol and alpha-tocopherol in morbid obesity and nonalcoholic fatty liver disease. |
Q38353525 | Role of fish oil in human health and possible mechanism to reduce the inflammation |
Q88654483 | Roles of Perilipins in Diseases and Cancers |
Q42361156 | Serum and Liver Tissue Metabonomic Study on Fatty Liver in Rats Induced by High-Fat Diet and Intervention Effects of Traditional Chinese Medicine Qushi Huayu Decoction |
Q37353943 | Steatocholecystitis and fatty gallbladder disease |
Q34088181 | Synergy analysis reveals association between insulin signaling and desmoplakin expression in palmitate treated HepG2 cells |
Q33594205 | Synthesis and anti-obesity effects in vivo of Crotadihydrofuran C as a novel PPARγ antagonist from Crotalaria albida |
Q36606602 | The Effect of Green Tea Extract Supplementation on Liver Enzymes in Patients with Nonalcoholic Fatty Liver Disease |
Q90749894 | The Potential of the FSP1cre-Pparb/d-/- Mouse Model for Studying Juvenile NAFLD |
Q26777980 | The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis |
Q45244529 | Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients |
Q90094530 | United States Pharmacopeia (USP) comprehensive review of the hepatotoxicity of green tea extracts |
Q43168054 | Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients |
Search more.